Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative recovery after ambulatory arthroscopic knee surgery
ChiCTR2100053014Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in disorders of knee (2 arms), sponsored by The First Affiliated Hospital, Anhui Medical University. Primary endpoint: Quality of postoperative recovery (QoR-15 total score). Started Dec 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
disorders of knee
Beyond the preview
Go deeper on ChiCTR2100053014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053014.